Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CREZET Tablet

View source ↗

Summary

The trial update indicates that CREZET Tablet testing for dyslipidemia is currently active but not recruiting, sponsored by Daewoong Pharmaceutical Co. LTD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• CREZET Tablet

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Dyslipidemias | Status: ACTIVE_NOT_RECRUITING